Clinical Trial Update: Dexmedetomidine in Seizure Patients [Phase 1]

View source ↗

Summary

This Phase 1 trial at UCSF evaluated dexmedetomidine in patients with epilepsy and has completed, focusing on safety and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: University of California, San Francisco | Conditions: Seizure Disorders | Phase 1 | Status: COMPLETED